CPH — Cipher Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- CA$339.41m
- CA$327.17m
- $50.45m
Brief: Cipher Pharmaceuticals Says CFO Stephen Lemieux Has Resigned
Canada Research Roundup: Cipher Pharmaceuticals, Ensign Energy, Integra Resources
Brief: Cipher Pharmaceuticals Q4 Loss Per Share $0.02 From Continuing Operations
Canada Research Roundup: Air Canada, Boralex, Westjet Airlines
Brief: Cipher Pharmaceuticals Says A-101 40 Pct Topical Solution Accepted For Review By Health Canada
Brief: Cipher Pharmaceuticals Announces Plecanatide Accepted For Review By Health Canada
Brief: Cipher Pharmaceuticals Q3 EPS $0.03 From Continuing Operations
Brief: Cipher Pharmaceuticals Announces Canadian Launch Of Brinavess
Brief: Cipher Pharmaceuticals Acquires Exclusive Canadian Rights To Mob-015 From Moberg Pharma
Brief: Moberg Pharma And Cipher Pharmaceuticals Sign Exclusive License Agreement For Mob-015 In Canada
Brief: Cipher Pharmaceuticals Receives Health Canada Approval Of Xydalba
Brief: Cipher Pharmaceuticals Reports Q2 EPS Of $0.07 From Continuing Operations
Brief: Cipher Pharmaceuticals Announces Amended Distribution And Supply Agreement For Absorica®
Brief: Cipher Pharmaceuticals Q1 Loss Per Share $0.04 From Continuing Operations
Brief: Cipher Pharma Provides Corporate Update And Preliminary Q1 2018 Revenue Results
Brief: Cipher Pharmaceuticals Acquires Canadian Rights To U.S. FDA-Approved A 101 40% Topical Solution
Brief: Cardiome Pharma To Pay $2.5 Mln Termination Fee To Cipher If Proposed Arrangement Not Completed
Cardiome Pharma: Soars as Cipher agrees to buy Canadian business
Brief: Cipher Pharmaceuticals And Cardiome Pharma Announce Strategic Transaction For Canadian Business Portfolio Of Cardiome